LOCUS: This is a study to monitor the long-term safety and tolerability of cell or gene therapy in people who have participated in prior AstraZeneca studiesA LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)

Trial purpose

Long-term follow-up

Tumor type

Multi-Cancer

Age

18 - 130

Trial acronym

LOCUS

Summary

This is a multi-centre and multinational basket study that will monitor the long-term safety and tolerability of cell or gene therapies in participants that have taken part in other AstraZeneca cell or gene therapy studies for up to 15 years.

Conditions

This trial is treating people with prior participation in an AstraZeneca study where they received a cell or gene therapy